(Q44024722)

29 November 2017

Annual number of lung cancer deaths potentially avertable by screening in the United States (English)

1 reference

29 November 2017

United States of America

0 references

1 reference

Jiemin Ma

1

1 reference

29 November 2017

Elizabeth M Ward

series ordinal

2

1 reference

29 November 2017

Robert Smith

series ordinal

3

1 reference

29 November 2017

Ahmedin Jemal

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

25 February 2013

1 reference

29 November 2017

1 reference

29 November 2017

119

1 reference

29 November 2017

1381-1385

1 reference

29 November 2017

7

1 reference

Reduced lung-cancer mortality with low-dose computed tomographic screening

29 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

Benefits and harms of CT screening for lung cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

Cost-effectiveness of computed tomography screening for lung cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27813

21 January 2018

Identifiers

DOI

10.1002/CNCR.27813

1 reference

29 November 2017

1 reference